{"id":"W2765131124","doi":"10.25251/skin.2.supp.54","title":"Omalizumab Retreatment of Patients with Chronic Idiopathic Urticaria/Spontaneous Urticaria (CIU/CS) Following Return of Symptoms: Primary Results of the Optima Study","year":2018,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Novartis Pharmaceuticals Canada; European Academy of Allergy and Clinical Immunology","keywords":"Medicine; Chronic urticaria; Omalizumab; Dermatology; Primary care; Immunology; Immunoglobulin E; Antibody; Family medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001399207,0.0003132567,0.001367615,0.0002692711,0.0002567395,0.0005743338,0.0003093825,0.0005156206,0.0008385289],"category_scores_gemma":[0.001683435,0.0002041552,0.0009640428,0.0001978134,0.0002515017,0.0004457803,0.0001823264,0.0007521288,0.0002504426],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002983248,"about_ca_system_score_gemma":0.0003017172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006871258,"about_ca_topic_score_gemma":0.001200008,"domain_scores_codex":[0.999598,0.0001752847,0.00003819061,0.00005160885,0.0000715579,0.0000653539],"domain_scores_gemma":[0.9992092,0.0002574593,0.000251615,0.00006014642,0.00004134934,0.00018029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3172922,0.0144962,0.3415571,0.00192836,0.005205141,0.001208981,0.0006270533,0.0007066001,0.01362302,0.0002020938,0.004290255,0.2988631],"study_design_scores_gemma":[0.03634772,0.07424082,0.8795635,0.0001764161,0.002871616,0.001835333,0.000279337,0.001050129,0.001318805,0.0001694678,0.002100037,0.00004677027],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962871,0.002710241,0.0000361787,0.0001042425,0.00003067289,0.00005421028,0.0001284867,0.000008955916,0.0006400108],"genre_scores_gemma":[0.9987087,0.000626241,0.0001031891,0.0001012153,0.00005917615,0.00002732709,0.00017312,0.000002075147,0.0001989623],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001399207,"threshold_uncertainty_score":0.007399797,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.005904810974161413,"score_gpt":0.2346256141413623,"score_spread":0.2287208031672009,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}